CLASS II Device recall · Reported 27 Nov 2019 · FDA Enforcement Report

Xcela, 8f Single Plastic Port Filled, Valved, Upn H965440400 recalled

Angiodynamics Inc. (Navilyst Medical Inc.) is recalling Xcela, 8f Single Plastic Port Filled, Valved, Upn H965440400, distributed nationwide in the US. The recall was initiated on 18 Sep 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes5480564
Quantity recalled582

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0505-2020
FDA event ID
83907
Recalling firm
Angiodynamics Inc. (Navilyst Medical Inc.), Glens Falls, NY
Classification
Class II
Status
Terminated
Recall initiated
18 Sep 2019
FDA classified
21 Nov 2019
Reported
27 Nov 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

18 Sep 2019Recall initiated by company
21 Nov 2019Classified by FDA+64 days
27 Nov 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Snap lock connectors provided within implantable port kits may not meet dimensional specifications, and the catheter cannot be inserted into the snap lock connector prior to connection to the port chamber, resulting in a delay to the implantation procedure.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

XCELA, 8F SINGLE PLASTIC PORT FILLED, VALVED, UPN H965440400, Cat. No. 44-040 - Product Usage: Long-term access to the central venous system for administration of fluids including but not limited to hydration fluids, chemotherapy, analgesics, nutritional therapy and blood products. The device is also indicated for blood specimen withdrawal.

Where it was distributed

Worldwide distribution - US Nationwide in the state of CA, CT, FL, GA, IA, IN, KS, KY, MI, MO, MS, MT, NE, NJ, NY, OH, OK, OR, PA, TN, TX, WA, WI and country of Canada.

Nationwide CaliforniaConnecticutFloridaGeorgiaIowaIndianaKansasKentuckyMichiganMissouriMississippiMontanaNebraskaNew JerseyNew YorkOhioOklahomaOregonPennsylvaniaTennessee

Questions about this recall

Why was it recalled?

Snap lock connectors provided within implantable port kits may not meet dimensional specifications, and the catheter cannot be inserted into the snap lock connector prior to connection to the port chamber, resulting in a delay to the implantation procedure.

Which lots are affected?

5480564

Where was it sold?

Worldwide distribution - US Nationwide in the state of CA, CT, FL, GA, IA, IN, KS, KY, MI, MO, MS, MT, NE, NJ, NY, OH, OK, OR, PA, TN, TX, WA, WI and country of Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

4 other products · FDA event 83907

This product is part of a recall event; the main page for the event is Bioflo 8f Single Titanium Non- Filled recalled.

More recalls from Angiodynamics Inc. (Navilyst Medical Inc.)

All 78

Other Other Medical Devices recalls

All 13,778